share_log

Stifel Upgrades Cipher Pharmaceuticals to Speculative Buy, Raises Price Target to $4.75

Stifel Upgrades Cipher Pharmaceuticals to Speculative Buy, Raises Price Target to $4.75

Stifel將Cipher Pharmicals上調至投機買入,將目標股價上調至4.75美元
Benzinga ·  2023/06/01 12:56

Stifel analyst Justin Keywood upgrades Cipher Pharmaceuticals (OTC:CPHRF) from Hold to Speculative Buy and raises the price target from C$0.95 to C$4.75.

Stifel分析師賈斯汀·基伍德將Cipher Pharmicals(場外交易代碼:CPHRF)從持有上調至投機性買入,並將目標股價從0.95加元上調至4.75加元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論